{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:51:30Z","timestamp":1785891090424,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIDA","award":["R01DA034806"],"award-info":[{"award-number":["R01DA034806"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00213-023-06524-2","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T07:02:02Z","timestamp":1703919722000},"page":"479-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The imidazoline I2 receptor agonist 2-BFI reduces abuse-related effects of morphine: self-administration and drug discrimination"],"prefix":"10.1007","volume":"241","author":[{"given":"Justin N.","family":"Siemian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Woodhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8103-7013","authenticated-orcid":false,"given":"Jun-Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,30]]},"reference":[{"key":"6524_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pbb.2012.01.024","volume":"101","author":"XF An","year":"2012","unstructured":"An XF, Zhang Y, Winter JC, Li JX (2012) Effects of imidazoline I(2) receptor agonists and morphine on schedule-controlled responding in rats. Pharmacol Biochem Behav 101:354\u2013359","journal-title":"Pharmacol Biochem Behav"},{"key":"6524_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000471","author":"A Bedin","year":"2016","unstructured":"Bedin A, CaldartBedin RA, Vieira JE, Ashmawi HA (2016) Duloxetine as an analgesic reduces opioid consumption after spine surgery: a randomized, double-blind, controlled study. Clin J Pain. https:\/\/doi.org\/10.1097\/AJP.0000000000000471","journal-title":"Clin J Pain"},{"key":"6524_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","volume":"162","author":"R Chou","year":"2015","unstructured":"Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA (2015) The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med 162:276\u2013286","journal-title":"Ann Intern Med"},{"key":"6524_CR4","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1124\/jpet.112.201616","volume":"344","author":"SM DeWire","year":"2013","unstructured":"DeWire SM, Yamashita DS, Rominger DH, Liu G, Cowan CL, Graczyk TM, Chen X-T, Pitis PM, Gotchev D, Yuan C, Koblish M, Lark MW, Violin JD (2013) A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther 344:708\u2013717","journal-title":"J Pharmacol Exp Ther"},{"key":"6524_CR5","first-page":"111","volume":"4","author":"F Ferrari","year":"2011","unstructured":"Ferrari F, Fiorentino S, Mennuni L, Garofalo P, Letari O, Mandelli S, Giordani A, Lanza M, Caselli G (2011) Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. J Pain Res 4:111\u2013125","journal-title":"J Pain Res"},{"key":"6524_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/BF02244992","volume":"114","author":"GA Higgins","year":"1994","unstructured":"Higgins GA, Wang Y, Corrigall WA, Sellers EM (1994) Influence of 5-HT3 receptor antagonists and the indirect 5-HT agonist, dexfenfluramine, on heroin self-administration in rats. Psychopharmacology 114:611\u2013619","journal-title":"Psychopharmacology"},{"key":"6524_CR7","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.tet.2006.11.077","volume":"63","author":"M Ishihara","year":"2007","unstructured":"Ishihara M, Togo H (2007) Direct oxidative conversion of aldehydes and alcohols to 2-imidazolines and 2-oxazolines using molecular iodine. Tetrahedron 63:1474\u20131480","journal-title":"Tetrahedron"},{"key":"6524_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1213\/ANE.0b013e3181cde882","volume":"110","author":"I Kissin","year":"2010","unstructured":"Kissin I (2010) The development of new analgesics over the past 50 years: a lack of real breakthrough drugs. Anesth Analg 110:780\u2013789","journal-title":"Anesth Analg"},{"key":"6524_CR9","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1111\/bph.12728","volume":"171","author":"M Lanza","year":"2014","unstructured":"Lanza M, Ferrari F, Menghetti I, Tremolada D, Caselli G (2014) Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats. Br J Pharmacol 171:3693\u20133701","journal-title":"Br J Pharmacol"},{"key":"6524_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00213-007-0914-9","volume":"195","author":"JX Li","year":"2008","unstructured":"Li JX, McMahon LR, France CP (2008) Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys. Psychopharmacology 195:479\u2013486","journal-title":"Psychopharmacology"},{"key":"6524_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2011.07.041","volume":"669","author":"JX Li","year":"2011","unstructured":"Li JX, Zhang Y, Winter JC (2011) Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I(2) receptor ligands. Eur J Pharmacol 669:59\u201365","journal-title":"Eur J Pharmacol"},{"key":"6524_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00213-012-2870-2","volume":"225","author":"JX Li","year":"2013","unstructured":"Li JX, Shah AP, Patel SK, Rice KC, France CP (2013) Modification of the behavioral effects of morphine in rats by serotonin 5-HT(1)A and 5-HT(2)A receptor agonists: antinociception, drug discrimination, and locomotor activity. Psychopharmacology 225:791\u2013801","journal-title":"Psychopharmacology"},{"key":"6524_CR13","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1111\/bph.12555","volume":"171","author":"J-X Li","year":"2014","unstructured":"Li J-X, Thorn DA, Qiu Y, Peng B-W, Zhang Y (2014) Antihyperalgesic effects of imidazoline I(2) receptor ligands in rat models of inflammatory and neuropathic pain. Brit J Pharmacol 171:1580\u20131590","journal-title":"Brit J Pharmacol"},{"key":"6524_CR14","doi-asserted-by":"crossref","unstructured":"Liu JF, Thorn DA, Zhang Y, Li JX (2016) Effects of trace amine-associated receptor 1 agonists on the expression, reconsolidation, and extinction of cocaine reward memory. Int J Neuropsychopharmacol 19(7):pyw009","DOI":"10.1093\/ijnp\/pyw009"},{"key":"6524_CR15","volume-title":"Pain in America NINDS Chronic Pain Information Page","author":"NIH","year":"2013","unstructured":"NIH (2013) Pain in America NINDS Chronic Pain Information Page. Bethesda, MD"},{"key":"6524_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1995.tb32397.x","volume":"763","author":"DJ Nutt","year":"1995","unstructured":"Nutt DJ, French N, Handley S, Hudson A, Husbands S, Jackson H, Jordan S, Lalies MD, Lewis J, Lione L et al (1995) Functional studies of specific imidazoline-2 receptor ligands. Ann N Y Acad Sci 763:125\u2013139","journal-title":"Ann N Y Acad Sci"},{"key":"6524_CR17","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1038\/srep06605","volume":"4","author":"Y Qiu","year":"2014","unstructured":"Qiu Y, He XH, Zhang Y, Li JX (2014) Discriminative stimulus effects of the novel imidazoline I(2) receptor ligand CR4056 in rats. Sci Rep 4:6605","journal-title":"Sci Rep"},{"key":"6524_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejphar.2015.01.013","volume":"749","author":"Y Qiu","year":"2015","unstructured":"Qiu Y, Zhang Y, Li JX (2015) Discriminative stimulus effects of the imidazoline I2 receptor ligands BU224 and phenyzoline in rats. Eur J Pharmacol 749:133\u2013141","journal-title":"Eur J Pharmacol"},{"key":"6524_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.joca.2019.09.002","volume":"28","author":"LC Rovati","year":"2020","unstructured":"Rovati LC, Brambilla N, Blicharski T, Connell J, Vitalini C, Bonazzi A, Giacovelli G, Girolami F, D\u2019Amato M (2020) Efficacy and safety of the first-in-class imidazoline-2 receptor ligand CR4056 in pain from knee osteoarthritis and disease phenotypes: a randomized, double-blind, placebo-controlled phase 2 trial. Osteoarthr Cartil 28:22\u201330","journal-title":"Osteoarthr Cartil"},{"key":"6524_CR20","doi-asserted-by":"publisher","first-page":"e74891","DOI":"10.1371\/journal.pone.0074891","volume":"8","author":"F Shen","year":"2013","unstructured":"Shen F, Tsuruda PR, Smith JA, Obedencio GP, Martin WJ (2013) Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model. PLoS ONE 8:e74891","journal-title":"PLoS ONE"},{"key":"6524_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00213-015-4166-9","volume":"233","author":"JN Siemian","year":"2016","unstructured":"Siemian JN, Li J, Zhang Y, Li JX (2016a) Interactions between imidazoline I2 receptor ligands and acetaminophen in adult male rats: antinociception and schedule-controlled responding. Psychopharmacology 233:873\u2013882","journal-title":"Psychopharmacology"},{"key":"6524_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/jpet.116.232421","volume":"357","author":"JN Siemian","year":"2016","unstructured":"Siemian JN, Obeng S, Zhang Y, Zhang Y, Li JX (2016b) Antinociceptive interactions between the imidazoline I2 receptor agonist 2-BFI and opioids in rats: role of efficacy at the mu-opioid receptor. J Pharmacol Exp Ther 357:509\u2013519","journal-title":"J Pharmacol Exp Ther"},{"key":"6524_CR23","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/bph.14161","volume":"175","author":"JN Siemian","year":"2018","unstructured":"Siemian JN, Wang K, Zhang Y, Li JX (2018) Mechanisms of imidazoline I(2) receptor agonist-induced antinociception in rats: involvement of monoaminergic neurotransmission. Br J Pharmacol 175:1519\u20131534","journal-title":"Br J Pharmacol"},{"key":"6524_CR24","doi-asserted-by":"crossref","unstructured":"Soergel DG, Subach RA, Burnham N, Lark MW, James IE, Sadler BM, Skobieranda F, Violin JD, Webster LR (2014) Biased agonism of the \u03bc-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. PAIN\u00ae 155:1829\u20131835","DOI":"10.1016\/j.pain.2014.06.011"},{"issue":"Suppl 1","key":"6524_CR25","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.pain.2013.09.009","volume":"154","author":"MD Sullivan","year":"2013","unstructured":"Sullivan MD, Howe CQ (2013) Opioid therapy for chronic pain in the United States: promises and perils. Pain 154(Suppl 1):S94-100","journal-title":"Pain"},{"key":"6524_CR26","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/npp.2016.91","volume":"41","author":"G Tanda","year":"2016","unstructured":"Tanda G, Mereu M, Hiranita T, Quarterman JC, Coggiano M, Katz JL (2016) Lack of specific involvement of (+)-naloxone and (+)-naltrexone on the reinforcing and neurochemical effects of cocaine and opioids. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 41:2772\u20132781","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"key":"6524_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ejphar.2011.09.173","volume":"670","author":"DA Thorn","year":"2011","unstructured":"Thorn DA, Zhang Y, Peng BW, Winter JC, Li JX (2011) Effects of imidazoline I(2) receptor ligands on morphine- and tramadol-induced antinociception in rats. Eur J Pharmacol 670:435\u2013440","journal-title":"Eur J Pharmacol"},{"key":"6524_CR28","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/j.1476-5381.2012.01894.x","volume":"166","author":"DA Thorn","year":"2012","unstructured":"Thorn DA, An X-F, Zhang Y, Pigini M, Li J-X (2012) Characterization of the hypothermic effects of imidazoline I2 receptor agonists in rats. Br J Pharmacol 166:1936\u20131945","journal-title":"Br J Pharmacol"},{"key":"6524_CR29","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/npp.2014.91","volume":"39","author":"DA Thorn","year":"2014","unstructured":"Thorn DA, Jing L, Qiu Y, Gancarz-Kausch AM, Galuska CM, Dietz DM, Zhang Y, Li JX (2014) Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 39:2309\u20132316","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"key":"6524_CR30","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s00213-015-3983-1","volume":"232","author":"DA Thorn","year":"2015","unstructured":"Thorn DA, Siemian JN, Zhang Y, Li JX (2015) Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone. Psychopharmacology 232:3309\u20133318","journal-title":"Psychopharmacology"},{"key":"6524_CR31","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/bph.13435","volume":"173","author":"DA Thorn","year":"2016","unstructured":"Thorn DA, Zhang Y, Li JX (2016) Effects of the imidazoline I receptor agonist 2-BFI on the development of tolerance and behavioral\/physical dependence to morphine in rats. Br J Pharmacol 173:1363\u20131372","journal-title":"Br J Pharmacol"},{"key":"6524_CR32","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/S0140-6736(11)60402-9","volume":"377","author":"DC Turk","year":"2011","unstructured":"Turk DC, Wilson HD, Cahana A (2011) Treatment of chronic non-cancer pain. Lancet 377:2226\u20132235","journal-title":"Lancet"},{"key":"6524_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1749-6632.1999.tb09382.x","volume":"881","author":"L Ugedo","year":"1999","unstructured":"Ugedo L, Pineda J, Martin-Ruiz R, Ruiz-Ortega JA, Artigas F (1999) Imidazoline-induced inhibition of firing rate of 5-HT neurons in rat dorsal raphe by modulation of extracellular 5-HT levels. Ann N Y Acad Sci 881:365\u2013368","journal-title":"Ann N Y Acad Sci"},{"key":"6524_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/BF02246185","volume":"120","author":"Y Wang","year":"1995","unstructured":"Wang Y, Joharchi N, Fletcher PJ, Sellers EM, Higgins GA (1995) Further studies to examine the nature of dexfenfluramine-induced suppression of heroin self-administration. Psychopharmacology 120:134\u2013141","journal-title":"Psychopharmacology"},{"key":"6524_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109\u2013110","journal-title":"Pain"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06524-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06524-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06524-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T06:03:23Z","timestamp":1708927403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06524-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,30]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["6524"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06524-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,30]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}